Compound Detail
CHEMBL439849
VILAZODONE 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
Basic Information
| ChEMBL ID | CHEMBL439849 |
| Name | VILAZODONE |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | SGEGOXDYSFKCPT-UHFFFAOYSA-N |
| Therapeutic | ✓ Yes |
25
Targets
51
Activities
3
Assay Types
30
PK Parameters
20
Publications
7
Known Names
4
Indications
Molecular Properties
441.5
MW (Da)
4.03
ALogP
5
HBA
2
HBD
102.3
PSA (Ų)
0.42
QED
0
Ro5 Violations
7
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 2011 |
| Availability | Prescription |
| Chirality | Achiral |
Indications
Depressive Disorder Anxiety Disorders Marijuana Abuse Memory Disorders
ATC Classification
N06AX24
vilazodone
Level 1: NERVOUS SYSTEM
Level 2: PSYCHOANALEPTICS
Activity Summary
IC50 38 meas. best 9.96
Ki 8 meas. best 9.7
EC50 5 meas. best 9.92
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| 5-hydroxytryptamine receptor 1A CHEMBL214 | IC50 | 9.96 | 9.83 | 0.1 | 2 |
| 5-hydroxytryptamine receptor 1A CHEMBL214 | EC50 | 9.92 | 9.49 | 0.1 | 5 |
| 5-hydroxytryptamine receptor 1A CHEMBL214 | Ki | 9.7 | 8.695 | 0.2 | 4 |
| 5-hydroxytryptamine receptor 1A CHEMBL273 | IC50 | 9.52 | 8.94 | 0.3 | 2 |
| Sodium-dependent serotonin transporter CHEMBL228 | IC50 | 9.4 | 9.338 | 0.4 | 5 |
| Sodium-dependent serotonin transporter CHEMBL228 | Ki | 9.3 | 9.01 | 0.5 | 2 |
| Sodium-dependent serotonin transporter CHEMBL313 | IC50 | 9.3 | 8.99 | 0.5 | 7 |
| D(3) dopamine receptor CHEMBL3138 | IC50 | 7.15 | 7.15 | 71.0 | 1 |
| D(2) dopamine receptor CHEMBL339 | IC50 | 7.02 | 6.6 | 95.0 | 2 |
| Sodium-dependent noradrenaline transporter CHEMBL222 | IC50 | 6.8 | 6.8 | 158.1 | 1 |
| 5-hydroxytryptamine receptor 4 CHEMBL4317 | IC50 | 6.6 | 6.6 | 252.0 | 1 |
| Sodium-dependent dopamine transporter CHEMBL238 | IC50 | 6.53 | 6.53 | 295.0 | 1 |
| Unchecked CHEMBL612545 | IC50 | 6.5 | 6.5 | 317.0 | 1 |
| D(2) dopamine receptor CHEMBL217 | Ki | 6.18 | 6.18 | 666.0 | 1 |
| 5-hydroxytryptamine receptor 2A CHEMBL322 | IC50 | 5.82 | 5.82 | 1510.0 | 1 |
| 5-hydroxytryptamine receptor 2C CHEMBL324 | IC50 | 5.7 | 5.7 | 2000.0 | 1 |
| Adrenergic receptor alpha-1 CHEMBL2094251 | IC50 | 5.7 | 5.7 | 1980.0 | 1 |
| 5-hydroxytryptamine receptor 7 CHEMBL3223 | IC50 | 5.52 | 5.52 | 3000.0 | 1 |
| 5-hydroxytryptamine receptor 6 CHEMBL3372 | IC50 | 5.52 | 5.52 | 3000.0 | 1 |
| D(4) dopamine receptor CHEMBL3361 | IC50 | 5.47 | 5.47 | 3400.0 | 1 |
| 5-hydroxytryptamine receptor 7 CHEMBL3155 | Ki | 5.41 | 5.41 | 3900.0 | 1 |
| 5-hydroxytryptamine receptor 1D CHEMBL5450 | IC50 | 5.4 | 5.4 | 4000.0 | 1 |
| Serotonin 3 (5-HT3) receptor CHEMBL2094116 | IC50 | 5.37 | 5.37 | 4300.0 | 1 |
| 5-hydroxytryptamine receptor 1B CHEMBL3459 | IC50 | 5.3 | 5.3 | 5000.0 | 1 |
| Voltage-gated inwardly rectifying potassium channel KCNH2 CHEMBL240 | IC50 | 5.26 | 5.255 | 5550.0 | 2 |
| Adrenergic receptor alpha-2 CHEMBL2095158 | IC50 | 5.22 | 5.22 | 6000.0 | 1 |
| Acetylcholinesterase CHEMBL3198 | IC50 | 4.67 | 4.67 | 21300.0 | 1 |
| Acetylcholinesterase CHEMBL3199 | IC50 | 4.67 | 4.67 | 21300.0 | 2 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| AUC | 409.0 | ng.hr.mL-1 | Rattus norvegicus |
| AUC | 791.0 | ng.hr.mL-1 | Canis lupus familiaris |
| AUC | 443.0 | ng.hr.mL-1 | Rattus norvegicus |
| AUC | 2020.0 | ng.hr.mL-1 | Canis lupus familiaris |
| AUC | 1645.0 | ng.hr.mL-1 | Homo sapiens |
| CL | 48590.0 | mL.min-1.g-1 | Rattus norvegicus |
| CL | 26000.0 | mL.min-1.g-1 | Homo sapiens |
| CL | 77.3 | mL.min-1.kg-1 | Rattus norvegicus |
| CL | 31.6 | mL.min-1.g-1 | Rattus norvegicus |
| CL | 30.1 | mL.min-1.g-1 | Mus musculus |
| CL | 49.3 | mL.min-1.g-1 | Mus musculus |
| CL | 51.59 | mL.min-1.g-1 | Homo sapiens |
| CL | 60.6 | mL.min-1.g-1 | Mus musculus |
| CL | 40.17 | mL.min-1.kg-1 | Rattus norvegicus |
| CL | 346.67 | mL.min-1.kg-1 | Canis lupus familiaris |
| Cmax | 0.488 | ug.mL-1 | Canis lupus familiaris |
| Cmax | 0.173 | ug.mL-1 | Rattus norvegicus |
| Cmax | 0.454 | ug.mL-1 | Canis lupus familiaris |
| Cmax | 0.156 | ug.mL-1 | Homo sapiens |
| F | 47.45 | % | Rattus norvegicus |
| F | 52.5 | % | Rattus norvegicus |
| T1/2 | 0.4753 | hr | Rattus norvegicus |
| T1/2 | 0.8887 | hr | Homo sapiens |
| T1/2 | 0.2983 | hr | Rattus norvegicus |
| T1/2 | 0.73 | hr | Rattus norvegicus |
| T1/2 | 0.6633 | hr | Mus musculus |
| T1/2 | 0.4683 | hr | Mus musculus |
| T1/2 | 0.4478 | hr | Homo sapiens |
| T1/2 | 0.3847 | hr | Mus musculus |
| T1/2 | 1.45 | hr | Rattus norvegicus |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
Data from ChEMBL 36 via Core Engine